1. Home
  2. RAYA vs INKT Comparison

RAYA vs INKT Comparison

Compare RAYA & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Erayak Power Solution Group Inc.

RAYA

Erayak Power Solution Group Inc.

HOLD

Current Price

$1.92

Market Cap

2.6M

ML Signal

HOLD

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

HOLD

Current Price

$11.88

Market Cap

59.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAYA
INKT
Founded
2019
2017
Country
China
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6M
59.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
RAYA
INKT
Price
$1.92
$11.88
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$35.00
AVG Volume (30 Days)
65.3K
11.5K
Earning Date
04-17-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.95
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.05
$8.48
52 Week High
$10.14
$16.80

Technical Indicators

Market Signals
Indicator
RAYA
INKT
Relative Strength Index (RSI) 36.68 52.38
Support Level $0.75 $10.82
Resistance Level $2.41 $12.04
Average True Range (ATR) 0.19 0.52
MACD -0.01 -0.01
Stochastic Oscillator 32.05 47.06

Price Performance

Historical Comparison
RAYA
INKT

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc is engaged in the manufacturing, research and development (R&D), and wholesale and retail of power solution products. The group focuses on manufacturing new energy storage and inverter devices. Its product portfolio includes sine wave and off-grid inverters, inverters and gasoline generators, battery and smart chargers, and custom-designed products. The products are used principally in agricultural and industrial vehicles, recreational vehicles (RVs), electrical appliances, and outdoor living products. The company generates the majority of its revenue from Inverters. The company generates revenue from five main markets, which are China, Poland, Mexico, the U.K., and Portugal. It derives maximum revenue from China.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.

Share on Social Networks: